
Bridging the Gap Between Patient Priorities and Clinical Trial Design
Will a new treatment restore a sense of normalcy, or will it disrupt the fundamental identity of the person seeking care? This question often dictates patient recruitment success, yet clinical trial protocols frequently overlook these personal trade-offs in favor of purely clinical metrics like efficacy and safety.

























